Hepatitis C. A clinical update
S. D. Colquhoun
Department of Surgery, University of California, Davis Medical Center, Sacramento, USA.
Hepatitis C virus is now known to be the causative agent for at least 90%
of non-A, non-B hepatitis cases. In the few years since its
characterization, much has been learned about this virus and the scope of
its disease. It now appears that close to 100% of infections may become
chronic, with delayed but potentially devastating consequences. The
treatment options for hepatitis C remain limited and less than
satisfactory. A vaccine seems to be a distant goal, but other strategies
for treatment may be closer. For now, the best option remains prevention.
